Clinical Criteria for RA & Early Non-Response to Certolizumab as Predictors of Patient Outcomes

A recent study compared three clinical criteria for rheumatoid arthritis (RA) in patients using certolizumab, assessing the predictability of treatment non-response. Researchers found Clinical Disease Activity Index measurement at three months may predict patient outcomes at 12 months...

Source: The Rheumatologist - May 25, 2020 Category: Rheumatology Authors: Lara C. Pullen, PhD Tags: Conditions Rheumatoid Arthritis Certolizumab Pegol Outcomes Rheumatoid Arthritis (RA) Source Type: research